Sun Pharma Staart 8-10% Winstr risk in the midst of 100% Trump rates, says HSBC. Can the giant navigate this?

The decision of the US government to impose a rate of 100% on imported patented medicines from 1 October could weigh on Sun Pharmaceutical Industries, the only major Indian drugstore with considerable exposure to innovative therapies in the US, HSBC said in a report of 26 September. The rate, which excludes companies that build factories […]

Madhu Kela family has delivered the importance in these small shares that in 2025 collected 80%. Do you have the possession?

Selection framework investors, including the Madhu Kela family and consumer-oriented investor Nikhil Vora, have raised their interests in GRM Overzee, a small capput food company whose shares have risen so far in 2025, underlines confidence in the company’s pivot. Promoters of GRM Overzee have a 2.65% interest for more than RS 58 Crore caught in […]

Hospital sector positioned for double digits; Apollo Hospitals, Max Healthcare Top Picks

The Indian hospital sector continues to produce robust growth, supported by persistent demand, capacity expansion and operational efficiency. In the past five years, the sector has clocked a healthy turnover of 16.5% and EBITDA CAGR of 26%, which reflects and improves the Fundamentals. In 1qfy26, sales increased by 16% yo -y, powered by higher patient […]

Emcure Pharmaceuticals reports a 41% rise in Q1 net profit powered by strong domestic and international growth

Pune-based Emcure Pharmaceuticals On Thursday, an increase of 41% reported on an annual basis of the net profit of the first quarter at RS 215 Crore. Turnover from the activities increased by 16% to RS 2,101 Crore, powered by robust performance in domestic and international companies. The EBITDA margins of the company for April-June was […]